New insights into IFN-γ in rheumatoid arthritis: role in the era of JAK inhibitors-Reference-Cited by-同舟云学术

New insights into IFN-γ in rheumatoid arthritis: role in the era of JAK inhibitors

Published:2020-04-02 Issue:2 Volume:43 Page:72-78
ISSN:2578-5826
Container-title:Immunological Medicine
language:en
Short-container-title:Immunological Medicine

Author:

Kato Masaru¹

Affiliation:

1. Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/25785826.2020.1751908

Reference64 articles.

1. Macrophage heterogeneity in the context of rheumatoid arthritis

2. A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-γ versus placebo in the treatment of rheumatoid arthritis

3. Randomized, double-blind trial of anti-interferon-?antibodies in rheumatoid arthritis

4. NCT00281294 Ctn. A phase 2 study to evaluate the safety, tolerability, and activity of fontolizumab in subjects with active rheumatoid arthritis. ClinicalTrialsgov.

5. Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The kynurenine pathway in patients with rheumatoid arthritis during tumor necrosis factor α inhibitors treatment;Rheumatology;2024-08-27

2. Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy;Journal of Translational Medicine;2024-08-05

3. Anti-inflammatory and anti-rheumatic effects of Phoenix dactylifera L. (date palm) seed by controlling cytokines and inhibiting JAK1/STAT3 pathway on CFA-induced arthritis rat and its phytochemical profiling;Journal of Ethnopharmacology;2024-07

4. Interferon-gamma signaling promotes cartilage regeneration after injury;Scientific Reports;2024-04-05

5. Liposomes: An Emerging Strategy for the Effective Treatment of Rheumatoid Arthritis;Current Rheumatology Reviews;2024-03-04